Loading
PDBj
MenuPDBj@FacebookPDBj@TwitterPDBj@YouTubewwPDB FoundationwwPDB
RCSB PDBPDBeBMRBAdv. SearchSearch help
PRD_000187
PRD_000187
Name:SCYPTOLIN A
Formula:C45 H71 Cl N8 O14
Definition date:2012-12-12
Last modified:2023-09-20
PRD_000952
PRD_000952
Name:N~2~-acetyl-N-[(2S,3R)-3-hydroxy-4-{[(4-methoxyphenyl)sulfonyl](2-methylpropyl)amino}-1-phenylbutan-2-yl]-L-isoleucinamide
Formula:C29 H43 N3 O6 S
Description:SYNTHETIC HIV-1 PROTEASE INHIBITOR
Definition date:2012-12-12
Last modified:2012-12-12
PRD_000193
PRD_000193
Name:Capreomycin IA
Formula:C25 H44 N14 O8
Definition date:2012-12-12
Last modified:2023-09-20
PRD_000953
PRD_000953
Name:N-[(2S,3R)-4-{(cyclohexylmethyl)[(4-methoxyphenyl)sulfonyl]amino}-3-hydroxy-1-phenylbutan-2-yl]-3-hydroxybenzamide
Formula:C31 H38 N2 O6 S
Description:SYNTHETIC HIV-1 PROTEASE INHIBITOR
Definition date:2012-12-12
Last modified:2012-12-12
PRD_000194
PRD_000194
Name:ACTAGARDINE
Formula:C81 H124 N20 O23 S4
Description:ACTAGARDINE IS A TRICYCLIC PEPTIDE. POST TRANSLATIONAL MATURATION OF LANTIBIOTICS INVOLVES THE ENZYMIC CONVERSION OF THR AND SER INTO DEHYDRATED AMINO ACIDS AND THE FORMATION OF THIOETHER BONDS WITH CYSTEINE. THE THIOETHER BONDS WITH CYSTEINE RESULT IN THREE RING STRUCTURES. THIS IS FOLLOWED BY MEMBRANE TRANSLOCATION AND CLEAVAGE OF THE MODIFIED PRECURSOR.
Definition date:2012-12-12
Last modified:2023-09-20
PRD_000954
PRD_000954
Name:3-hydroxy-N-[(2S,3R)-3-hydroxy-4-{[(4-methoxyphenyl)sulfonyl](3-phenylpropyl)amino}-1-phenylbutan-2-yl]benzamide
Formula:C33 H36 N2 O6 S
Description:SYNTHETIC HIV-1 PROTEASE INHIBITOR
Definition date:2012-12-12
Last modified:2012-12-12
PRD_000195
PRD_000195
Name:Cinnamycin
Formula:C89 H127 N25 O25 S3
Description:CINNAMYCIN IS A TETRACYCLIC PEPTIDE. POST TRANSLATIONAL MATURATION OF LANTIBIOTICS INVOLVES THE ENZYMIC CONVERSION OF THR AND SER INTO DEHYDRATED AMINO ACIDS AND THE FORMATION OF THIOETHER BONDS WITH CYSTEINE. THE 14-19 BETA-METHYLLANTHIONINE THIOETHER BOND IS OXIDIZED TO A SULFOXIDE. THE THIOETHER BONDS WITH CYSTEINE RESULT IN THREE RING STRUCTURES, CROSSLINK BETWEEN SER AND LYS RESULT IN THE FOURTH RING. THIS IS FOLLOWED BY MEMBRANE TRANSLOCATION AND CLEAVAGE OF THE MODIFIED PRECURSOR.
Definition date:2012-12-12
Last modified:2023-09-20
PRD_000955
PRD_000955
Name:3-hydroxy-N-{(2S,3R)-3-hydroxy-4-[(2-methylpropyl){[5-(1,2-oxazol-5-yl)thiophen-2-yl]sulfonyl}amino]-1-phenylbutan-2-yl}benzamide
Formula:C28 H31 N3 O6 S2
Description:SYNTHETIC HIV-1 PROTEASE INHIBITOR
Definition date:2012-12-12
Last modified:2012-12-12
PRD_000196
PRD_000196
Name:EPILANCIN 15X
Formula:C145 H241 N41 O33 S3
Description:Epilancin 15X is a tricyclic peptide. thioether bonds with cysteine result in three rings along the peptide chain. Post Translational maturation of lantibiotics involves the enzymic conversion of Thr and Ser into dehydrated amino acids and the formation of thioether bonds with cysteine. This is followed by membrane translocation and cleavage of the modified precursor.
Definition date:2012-12-12
Last modified:2023-09-20
PRD_000197
PRD_000197
Name:ALPHA LICHENICIDIN PREPEPTIDE
Formula:C142 H226 N36 O41 S5
Description:LICHENICIDIN VK21 IS A TETRACYCLIC PEPTIDE. POST TRANSLATIONAL MATURATION OF LANTIBIOTICS INVOLVES THE ENZYMIC CONVERSION OF THR, AND SER INTO DEHYDRATED AMINO ACIDS AND THE FORMATION OF THIOETHER BONDS WITH CYSTEINE. THIOETHER BONDS WITH CYSTEINE RESULT IN FOUR RINGS. THIS IS FOLLOWED BY MEMBRANE TRANSLOCATION AND CLEAVAGE OF THE MODIFIED PRECURSOR.
Definition date:2012-12-12
Last modified:2023-11-03
PRD_000198
PRD_000198
Name:BETA LICHENICIDIN PREPEPTIDE
Formula:C133 H200 N36 O37 S4
Description:LICHENICIDIN VK21 IS A TETRACYCLIC PEPTIDE. POST TRANSLATIONAL MATURATION OF LANTIBIOTICS INVOLVES THE ENZYMIC CONVERSION OF THR, AND SER INTO DEHYDRATED AMINO ACIDS AND THE FORMATION OF THIOETHER BONDS WITH CYSTEINE. THIOETHER BONDS WITH CYSTEINE RESULT IN FOUR RINGS. THIS IS FOLLOWED BY MEMBRANE TRANSLOCATION AND CLEAVAGE OF THE MODIFIED PRECURSOR.
Definition date:2012-12-12
Last modified:2023-11-03
PRD_000959
PRD_000959
Name:4-(benzyloxy)-N-[(2S,3R)-3-hydroxy-1-{[(2S)-1-{[(3-methylthiophen-2-yl)methyl]amino}-1-oxo-4-phenylbutan-2-yl]amino}-1-oxobutan-2-yl]benzamide
Formula:C34 H37 N3 O5 S
Definition date:2012-12-12
Last modified:2012-12-12
PRD_000199
PRD_000199
Name:Mersacidin
Formula:C80 H120 N20 O21 S4
Description:MERSACIDIN IS A TETRACYCLIC PEPTIDE. POST TRANSLATIONAL MATURATION OF LANTIBIOTICS INVOLVES THE ENZYMIC CONVERSION OF THR, AND SER INTO DEHYDRATED AA AND THE FORMATION OF THIOETHER BONDS WITH CYSTEINE. THE CARBOXY-TERMINAL BETA-METHYLLANTHIONINE UNDERGOES DECARBOXYLATION. THIOETHER BONDS WITH CYSTEINE RESULT IN FOUR RINGS. THIS IS FOLLOWED BY MEMBRANE TRANSLOCATION AND CLEAVAGE OF THE MODIFIED PRECURSOR.
Definition date:2012-12-12
Last modified:2023-09-20
PRD_000200
PRD_000200
Name:Nisin A
Formula:C141 H233 N41 O38 S7
Description:Nisin Z is a heptacyclic peptide. Post Translational maturation of lantibiotics involves the enzymic conversion of Thr, and Ser into dehydrated AA and the formation of thioether bonds with cysteine. Thioether bonds with cysteine result in five cyclic structures along the peptide chain. This is followed by membrane translocation and cleavage of the modified precursor.
Definition date:2012-12-12
Last modified:2023-09-20
PRD_000964
PRD_000964
Name:N-(benzylsulfonyl)-D-alanyl-N-[2-(aminomethyl)-5-chlorobenzyl]-L-prolinamide
Formula:C23 H29 Cl N4 O4 S
Definition date:2012-12-12
Last modified:2012-12-12
PRD_000201
PRD_000201
Name:Alpha-Amanitin
Formula:C39 H54 N10 O14 S
Description:ALPHA-AMANITIN, IS AN 8 AMINO-ACID PEPTIDE. THE OUTER LOOP IS FORMED BY A PEPTIDE BOND BETWEEN THE C- AND THE N-TERMINI. THE SIDE-CHAINS OF RESIDUES 2 AND 8 ARE LINKED TO FORM THE INNER LOOP.
Definition date:2012-12-12
Last modified:2023-09-20
PRD_000966
PRD_000966
Name:[(5S)-5-[[(2S)-6-azaniumyl-2-[[(2S)-6-azaniumyl-2-[2-[[(2S)-2-[[(2S)-2-[[(2S,5S,8S,11S,20S)-20-[[(2S)-2-[[(2S,3R)-2-[[(2S,3S)-2-azanyl-3-methyl-pentanoyl]amino]-3-oxidanyl-butanoyl]amino]-3-phenyl-propanoyl]amino]-2-(2-hydroxy-2-oxoethyl)-11,20-dimethyl-5,8-bis(2-methylpropyl)-3,6,9,21-tetrakis(oxidanylidene)-1,4,7,10-tetrazacyclohenicos-11-yl]carbonylamino]-3-(4-hydroxyphenyl)propanoyl]amino]-3-(4-hydroxyphenyl)propanoyl]amino]ethanoylamino]hexanoyl]amino]hexanoyl]amino]-6-oxidanyl-6-oxidanylidene-hexyl]azanium
Formula:C87 H140 N17 O20
Definition date:2012-12-12
Last modified:2013-06-03
PRD_000203
PRD_000203
Name:Chloroorienticin A
Formula:C73 H88 Cl2 N10 O26
Description:CHLOROORIENTICIN A IS A TRICYCLIC GLYCOPEPTIDE, GLYCOSYLATED BY ONE DISACCHARIDE ON RESIDUE 4 AND ONE MONOSACCHARIDE ON RESIDUE 6.
Definition date:2012-12-12
Last modified:2023-09-20
PRD_000204
PRD_000204
Name:Vancomycin
Formula:C66 H75 Cl2 N9 O24
Description:VANCOMYCIN IS A TRICYCLIC GLYCOPEPTIDE, GLYCOSYLATED BY A DISACCHARIDE (RESIDUES 8 AND 9) ON RESIDUE 4.
Definition date:2012-12-12
Last modified:2022-01-06
PRD_000205
PRD_000205
Name:DESVANCOSAMINYL VANCOMYCIN
Formula:C59 H62 Cl2 N8 O22
Description:DESVANCOSAMINYL VANCOMYCIN IS AN INTERMIDIATE IN VANCOMYCIN BIOSYNTHESIS. IT IS TRICYCLIC GLYCOPEPTIDE, GLYCOSYLATED BY D-GLUCOSE (RESIDUE 8) ON RESIDUE 4.
Definition date:2012-12-12
Last modified:2023-09-20
PRD_000971
PRD_000971
Name:N-acetylglycyl-N-[(3S)-1-hydroxy-5-methyl-2-oxohexan-3-yl]-L-serinamide
Formula:C14 H25 N3 O6
Definition date:2012-12-12
Last modified:2012-12-12
PRD_000206
PRD_000206
Name:VANCOMYCIN AGLYCON
Formula:C53 H52 Cl2 N8 O17
Description:VANCOMYCIN AGLYCON IS THE NONSUGAR COMPONENT OF VANCOMYCIN, CONSISTING OF THE TRICYCLIC HEPTAPEPTIDE ONLY.
Definition date:2012-12-12
Last modified:2023-09-20
PRD_000972
PRD_000972
Name:N-(benzylsulfonyl)-D-valyl-N-[2-(aminomethyl)-5-chlorobenzyl]-L-prolinamide
Formula:C25 H33 Cl N4 O4 S
Definition date:2012-12-12
Last modified:2012-12-12
PRD_000207
PRD_000207
Name:Decaplanin
Formula:C72 H86 Cl N9 O28
Description:DECAPLANIN IS A TRICYCLIC GLYCOPEPTIDE. THE SCAFFOLD IS A HEPTAPEPTIDE WITH THE CONFIGURATION D-D-L-D-D-L-L, GLYCOSYLATED
Definition date:2012-12-12
Last modified:2023-09-20
PRD_000209
PRD_000209
Name:Teicoplanin A2-2 beta-D-Glucopyranuronic acid
Formula:C88 H97 Cl2 N9 O33
Definition date:2012-12-12
Last modified:2023-09-20

221051

PDB entries from 2024-06-12

PDB statisticsPDBj update infoContact PDBjnumon